228 related articles for article (PubMed ID: 22251999)
21. [Cost-effectiveness of prophylaxis and treatment of influenza].
Rychlik R; Heinen-Kammerer T; Rusche H; Piercy J; Scuffham P; Zöllner Y
Dtsch Med Wochenschr; 2003 Oct; 128(43):2267-70. PubMed ID: 14574642
[No Abstract] [Full Text] [Related]
22. Cost-effectiveness of a recommendation of universal mass vaccination for seasonal influenza in the United States.
Clements KM; Chancellor J; Nichol K; DeLong K; Thompson D
Value Health; 2011; 14(6):800-11. PubMed ID: 21914499
[TBL] [Abstract][Full Text] [Related]
23. A systematic review and meta-analysis of the direct epidemiological and economic effects of seasonal influenza vaccination on healthcare workers.
Imai C; Toizumi M; Hall L; Lambert S; Halton K; Merollini K
PLoS One; 2018; 13(6):e0198685. PubMed ID: 29879206
[TBL] [Abstract][Full Text] [Related]
24. [Cost-effectiveness of vaccines for the prevention of seasonal influenza in different age groups: a systematic review].
Valcárcel Nazco C; García Lorenzo B; Del Pino Sedeño T; García Pérez L; Brito García N; Linertová R; Ferrer Rodríguez J; Imaz Iglesia I; Serrano Aguilar P
Rev Esp Salud Publica; 2018 Oct; 92():. PubMed ID: 30327454
[TBL] [Abstract][Full Text] [Related]
25. [Cost-effectiveness of influenza vaccination The Netherlands].
Reinders A; Postma MJ; Govaert TM; Sprenger MJ
Ned Tijdschr Geneeskd; 1997 Jan; 141(2):93-7. PubMed ID: 9036354
[TBL] [Abstract][Full Text] [Related]
26. Optimising age coverage of seasonal influenza vaccination in England: A mathematical and health economic evaluation.
Hill EM; Petrou S; Forster H; de Lusignan S; Yonova I; Keeling MJ
PLoS Comput Biol; 2020 Oct; 16(10):e1008278. PubMed ID: 33021983
[TBL] [Abstract][Full Text] [Related]
27. Public health and economic impact of seasonal influenza vaccination with quadrivalent influenza vaccines compared to trivalent influenza vaccines in Europe.
Uhart M; Bricout H; Clay E; Largeron N
Hum Vaccin Immunother; 2016 Sep; 12(9):2259-68. PubMed ID: 27166916
[TBL] [Abstract][Full Text] [Related]
28. Net Costs Due to Seasonal Influenza Vaccination--United States, 2005-2009.
Carias C; Reed C; Kim IK; Foppa IM; Biggerstaff M; Meltzer MI; Finelli L; Swerdlow DL
PLoS One; 2015; 10(7):e0132922. PubMed ID: 26230271
[TBL] [Abstract][Full Text] [Related]
29. Cost-effectiveness analysis of influenza and pneumococcal vaccination for Hong Kong elderly in long-term care facilities.
You JH; Wong WC; Ip M; Lee NL; Ho SC
J Epidemiol Community Health; 2009 Nov; 63(11):906-11. PubMed ID: 19608558
[TBL] [Abstract][Full Text] [Related]
30. French economic evaluations of influenza and influenza vaccination.
Levy E
Pharmacoeconomics; 1996; 9 Suppl 3():62-6. PubMed ID: 10160489
[TBL] [Abstract][Full Text] [Related]
31. [Pharmaco-economics of anti-influenza vaccinations].
Jahnz-Rózyk K
Pol Merkur Lekarski; 2003 Jun; 14(84):679-81. PubMed ID: 14524303
[TBL] [Abstract][Full Text] [Related]
32. Epidemiologic and economic impact of pharmacies as vaccination locations during an influenza epidemic.
Bartsch SM; Taitel MS; DePasse JV; Cox SN; Smith-Ray RL; Wedlock P; Singh TG; Carr S; Siegmund SS; Lee BY
Vaccine; 2018 Nov; 36(46):7054-7063. PubMed ID: 30340884
[TBL] [Abstract][Full Text] [Related]
33. Cost-effectiveness of influenza vaccination in working-age cancer patients.
Avritscher EB; Cooksley CD; Geraci JM; Bekele BN; Cantor SB; Rolston KV; Elting LS
Cancer; 2007 Jun; 109(11):2357-64. PubMed ID: 17457827
[TBL] [Abstract][Full Text] [Related]
34. Economic evaluation of influenza vaccination. Assessment for The Netherlands.
Postma MJ; Bos JM; van Gennep M; Jager JC; Baltussen R; Sprenger MJ
Pharmacoeconomics; 1999; 16 Suppl 1():33-40. PubMed ID: 10623374
[TBL] [Abstract][Full Text] [Related]
35. Mitigation of pandemic influenza: review of cost-effectiveness studies.
Lugnér AK; Postma MJ
Expert Rev Pharmacoecon Outcomes Res; 2009 Dec; 9(6):547-58. PubMed ID: 19941432
[TBL] [Abstract][Full Text] [Related]
36. Influenza vaccines in low and middle income countries: a systematic review of economic evaluations.
Ott JJ; Klein Breteler J; Tam JS; Hutubessy RC; Jit M; de Boer MR
Hum Vaccin Immunother; 2013 Jul; 9(7):1500-11. PubMed ID: 23732900
[TBL] [Abstract][Full Text] [Related]
37. Economic value of seasonal and pandemic influenza vaccination during pregnancy.
Beigi RH; Wiringa AE; Bailey RR; Assi TM; Lee BY
Clin Infect Dis; 2009 Dec; 49(12):1784-92. PubMed ID: 19911967
[TBL] [Abstract][Full Text] [Related]
38. Public health and economic benefits of new pediatric influenza vaccination programs in Argentina.
Giglio N; Gentile A; Lees L; Micone P; Armoni J; Reygrobellet C; Crépey P
Hum Vaccin Immunother; 2012 Mar; 8(3):312-22. PubMed ID: 22330959
[TBL] [Abstract][Full Text] [Related]
39. Seasonal influenza vaccination of healthy working-age adults: a review of economic evaluations.
Gatwood J; Meltzer MI; Messonnier M; Ortega-Sanchez IR; Balkrishnan R; Prosser LA
Drugs; 2012 Jan; 72(1):35-48. PubMed ID: 22191794
[TBL] [Abstract][Full Text] [Related]
40. Vaccination of healthy children against seasonal influenza: a European perspective.
Heikkinen T; Tsolia M; Finn A
Pediatr Infect Dis J; 2013 Aug; 32(8):881-8. PubMed ID: 23856713
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
